Groves, Ryan A.
Chan, Carly C. Y.
Wildman, Spencer D.
Gregson, Daniel B.
Rydzak, Thomas
Lewis, Ian A.
Funding for this research was provided by:
Canada Foundation for Innovation
Alberta Innovates (Translational Health Chair)
Genome Alberta
Canadian Institutes of Health Research
Genome Canada
Article History
Received: 31 May 2022
Revised: 23 September 2022
Accepted: 13 October 2022
First Online: 28 November 2022
Declarations
:
: This study was approved by the conjoint health research ethics board approved protocols (REB19-0442, REB18-0233, and REB17-1525). Biological materials were obtained for this study from Alberta Precision Laboratories in compliance with these approved ethics protocols.
: I.A.L., R.A.G., and D.B.G. submitted a patent (WO/2019/227235) describing the use of LC–MS for the detection of urinary tract infections. All other authors have no competing interests. This research was funded by a Genome Canada GAPP award, which is intended to enable the commercialization of research findings.